October 27 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said on Friday its sales revenue rose by an annual 9% to 485.9 million levs ($288.8 million/248.6 million euro) in the first nine months of 2017.
The company’s pre-tax profit amounted to 11.3 million levs in the January-September period, Sopharma Trading said in a bourse filing.
In September alone, sales revenue increased by an annual 4% to 53.3 million levs.
The drug distributor’s pre-tax profit totalled 1.1 million levs in September.
Sopharma Trading closed flat at 7.115 levs on the Sofia stock exchange on Thursday.
(1 euro = 1.95583 levs)